| Impact of CT screening in lung cancer: Scientific evidence and literature review K Kennedy, A Hulbert, M Pasquinelli, LE Feldman Seminars in Oncology 49 (3-4), 198-205, 2022 | 10 | 2022 |
| Myo1e overexpression in lung adenocarcinoma is associated with increased risk of mortality I Jusue-Torres, R Tiv, JC Ricarte-Filho, A Mallisetty, L Contreras-Vargas, ... Scientific Reports 13 (1), 4107, 2023 | 6 | 2023 |
| Surgery for early-stage lung cancer with video-assisted thoracoscopic surgery versus open thoracotomy: A narrative review J Alban, K Kennedy, A Hulbert, M Lighter, M Pasquinelli, I Rubinstein, ... Seminars in Oncology 49 (3-4), 261-264, 2022 | 4 | 2022 |
| The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment K Kennedy, K Khaddour, N Ramnath, F Weinberg The Cancer Journal 29 (2), 61-69, 2023 | 3 | 2023 |
| Neighborhood-level deprivation and survival in lung cancer K Kennedy, I Jusue-Torres, ID Buller, E Rossi, A Mallisetty, K Rodgers, ... BMC cancer 24 (1), 959, 2024 | | 2024 |
| The intersection of neighborhood-level disadvantage and overall lung cancer survival. K Kennedy, I Jusue-Torres, I Buller, E Rossi, A Mallisetty, K Rodgers, ... Journal of Clinical Oncology 41 (16_suppl), 6551-6551, 2023 | | 2023 |
| FP04. 04 A Phase Ib/II Study of Imprime PGG and Pembrolizumab in Pretreated Patients With Advanced Stage Non-Small Cell Lung Cancer: BTCRC-LUN15-017 M Furqan, J Malhotra, L Liu, H Wang, M Pasquinelli, E Sisel, K Kennedy, ... Journal of Thoracic Oncology 16 (10), S951-S952, 2021 | | 2021 |
| P77. 05 Phase II Study of Imprime PGG and Pembrolizumab in Stage IV NSCLC After Progression on First-Line Therapy: BTCRC-LUN15-017 E Sisel, M Furqan, J Malhotra, A Shergill, K Kennedy, L Liu, M Pasquinelli, ... Journal of Thoracic Oncology 16 (3), S637, 2021 | | 2021 |
